What is IART's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 1.05B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for IART?

P/E (TTM) is n/a and 52-week range is $8.70 to $20.49 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s IART figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for IART?

The company profile lists revenue (TTM) near $1.64B, net income (TTM) near $-721M, EPS (TTM) near $-0.10 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Integra Lifesciences Holdings Corp based, and what identifiers does Chartloom list?

The company context section lists headquarters in Princeton, New Jersey, US, 77.8M shares outstanding, ISIN US4579852082 when available from company profile and filing metadata.

Integra Lifesciences Holdings Corp

$IART

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$13.44

+0.22%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,427 full-time employees. The company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The company provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.

Employees

4,427

Website

www.integralife.com/

IPO

1995-08-16

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)